Literature DB >> 8306469

Decreased psychological well-being in adult patients with growth hormone deficiency.

T Rosén1, L Wirén, L Wilhelmsen, I Wiklund, B A Bengtsson.   

Abstract

OBJECTIVE: Besides effects on body composition, bone mineral content and lipid metabolism, GH seems to influence quality of life, according to previous studies of limited numbers of patients with GH deficiency of childhood and adult origin. In this study psychological well-being was assessed in a large number of patients with GH deficiency of adult origin.
DESIGN: A follow-up study of patients with hypopituitarism on routine replacement therapy with L-thyroxine, cortisone acetate and sex steroids. PATIENTS: Eighty-six patients (51 men, mean age 55.4 years and 35 women, mean age 54.9 years) diagnosed as having growth hormone deficiency on the basis of low IGF-I concentration or a maximum GH response less than 5 mU/l after an insulin/glucagon tolerance test. MEASUREMENTS: Quality of life was measured with a self-rating questionnaire, the Nottingham Health Profile, and the results were compared with the results from 86 controls matched for age, gender, marital status and socioeconomic class. Furthermore, the observed and expected number of disablement pensions were calculated.
RESULTS: The mean total score of the patients was higher, i.e. worse (P < 0.05), than that of the matching controls, indicating a higher level of perceived health problems among the patients. There were higher scores (poorer life quality) for energy (P < 0.001), social isolation (P < 0.01), emotional reaction (P = 0.056) and sex life (P < 0.001) among patients compared with controls. Finally, the observed number of disablement pension among the patients tended to be higher than expected (19 vs 12.4, P = 0.09).
CONCLUSIONS: Adult patients with GH deficiency have a decreased psychological well-being in terms of energy, social isolation and emotional reaction and a disturbed sex life compared with normals. Furthermore, there is a tendency to a higher frequency of early retirement.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8306469     DOI: 10.1111/j.1365-2265.1994.tb02452.x

Source DB:  PubMed          Journal:  Clin Endocrinol (Oxf)        ISSN: 0300-0664            Impact factor:   3.478


  35 in total

1.  Intestinal permeability in adult patients with growth hormone deficiency.

Authors:  J García-Arnés; C Sierra; F Tinahones; A Monzón; M J López; N Mazuecos; F Soriguer; E Valverde
Journal:  J Endocrinol Invest       Date:  2001-02       Impact factor: 4.256

Review 2.  Long-term growth hormone replacement therapy in hypopituitary adults.

Authors:  Johan Verhelst; Roger Abs
Journal:  Drugs       Date:  2002       Impact factor: 9.546

3.  [Hypopituitarism in adulthood: diagnosis and therapy].

Authors:  Johannes Hensen
Journal:  Med Klin (Munich)       Date:  2009-03-15

Review 4.  Quality-of-life assessment of adults with growth hormone deficiency. Implications for drug therapy.

Authors:  S P McKenna; L C Doward
Journal:  Pharmacoeconomics       Date:  1994-11       Impact factor: 4.981

5.  Growth hormone replacement in adults.

Authors:  S M Shalet; S J Holmes
Journal:  BMJ       Date:  1994-05-21

Review 6.  Growth hormone and cognitive function.

Authors:  Fred Nyberg; Mathias Hallberg
Journal:  Nat Rev Endocrinol       Date:  2013-04-30       Impact factor: 43.330

7.  Changes in insulin levels following 6-month treatment with recombinant human growth hormone in growth hormone-deficient adults.

Authors:  D Valle; M N D Di Minno; V Palmieri; S Pezzullo; F Cirillo; C Di Somma; G Di Minno; G Lombardi
Journal:  J Endocrinol Invest       Date:  2009-07-17       Impact factor: 4.256

8.  [Reduced incidence of side-effects of growth hormone substitution in 404 patients with hypophyseal insufficiency. Results of a multicenter indications study].

Authors:  C Wüster; U Melchinger; T Eversmann; J Hensen; P Kann; A von zur Mühlen; M B Ranke; H Schmeil; H Steinkamp; U Tuschy
Journal:  Med Klin (Munich)       Date:  1998-10-15

Review 9.  [Growth hormone therapy in adults. Attempt to assess a decade of use].

Authors:  M Faust; C J Strasburger
Journal:  Internist (Berl)       Date:  2008-05       Impact factor: 0.743

10.  A possible connection between psychosomatic symptoms and daily rhythmicity in growth hormone secretion in healthy Japanese students.

Authors:  Mitsuo Nagane; Kazunori Yoshimura; Shu-Ichi Watanabe; Masahiko Nomura
Journal:  J Circadian Rhythms       Date:  2009-08-05
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.